Patients in the third month of their protocol often describe the change not just as less pain but as a qualitative shift in how the injured area functions by month three: more fluid movement, faster recovery, and less restriction than before the protocol started
BPC-157 is not approved for human use by the MHRA in the UK or the FDA in the US
Dosage and Administration: Inject subcutaneously or intramuscularly
PT-141 PT-141 is a peptide hormone that is used to treat sexual dysfunction in both men and women
Thymosin beta-4 and its derivatives, including TB-500, are listed under peptide hormones, growth factors, related substances and mimetics
If you want to optimise your microneedling protocol: The data suggests that longer treatment duration (36 months minimum) and less aggressive session frequency (fortnightly rather than weekly) may actually produce better results than trying to do more, more often